IndraLab

Statements


USP3 activates MYC. 2 / 2
| 2

reach
"These findings suggest that USP3 modulates ccRCC progression by stabilizing MYC, highlighting its potential as a therapeutic target in ccRCC treatment."

reach
"USP3 promotes clear cell renal cell carcinoma progression by stabilizing MYC and enhancing glycolysis."